Phase I Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed and Refractory Solid Tumors and Leukemias
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide (Primary) ; Etoposide (Primary)
- Indications Leukaemia; Solid tumours
- Focus Adverse reactions
- 18 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 18 Sep 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2018.
- 05 Aug 2015 New trial record